Shares Held (Direct Ownership) 104K
n/a 3M change
n/a 12M change
Total Value Held N/A

Gina Chapman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 19 2024
SELL
Open market or private sale
$74,464 $25.03 p/Share
2,975 Reduced 2.78%
103,905 Common Stock
Sep 19 2024
BUY
Exercise of conversion of derivative security
$14,964 $5.03 p/Share
2,975 Added 2.71%
106,880 Common Stock
Sep 18 2024
SELL
Open market or private sale
$179,794 $25.09 p/Share
7,166 Reduced 6.45%
103,905 Common Stock
Sep 18 2024
BUY
Exercise of conversion of derivative security
$36,044 $5.03 p/Share
7,166 Added 6.06%
111,071 Common Stock

Also insider at

TRDA
Entrada Therapeutics, Inc. Healthcare
GC

Gina Chapman

President & CEO
Boston, MA

Track Institutional and Insider Activities on CRGX

Follow CARGO Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRGX shares.

Notify only if

Insider Trading

Get notified when an Cargo Therapeutics, Inc. insider buys or sells CRGX shares.

Notify only if

News

Receive news related to CARGO Therapeutics, Inc.

Track Activities on CRGX